Anass Hammich     2 Accountancy & Tax 3Jordi Casteleyn  <br />Pfizer	<br />
Summary<br />History<br />Turnover 2009 – 2010 – Q1<br />Turnover 2009 – 2010 – Q2<br />Turnover 2009 – 2010 – Q3<br />Tur...
History<br />Pfizer is named after the German-American cousins Charles Pfizer and Charles Erhat (born in germany)<br />The...
Turnover 2010 – 2009 - Q1<br />
Conclusion Q1<br />The Biopharmaceutical has increased with 44% since last year<br />The salesnumbers of the diversified p...
Turnover 2010 – 2009 – Q2<br />
Conclusion Q2<br />When we compare the Bioparmaceutical of the 2nd quarter, we can see that it has an increase of 49%.<br ...
Turnover 2010 – 2009 – Q3<br />
Conclusion Q3<br />The total of this quarter has the least salesnumbers opposite the other 3 quarters.<br />When we compar...
Turnover 2010 – 2009 – Q4<br />
Conclusion Q4<br />The turnover has climbed since last year<br />The recent 4th quarter is better then the 4th quarter of ...
Ratio Pfizer Belgium “Puurs”<br />
Sources<br />http://www.pfizer.be/sites/be/nl/about_pfizer/who_we_are/history/Pages/default.aspx <br />http://www.pfizer.c...
Upcoming SlideShare
Loading in …5
×

Anass hammich pfizer slidecast

499 views

Published on

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
499
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Anass hammich pfizer slidecast

  1. 1. Anass Hammich 2 Accountancy & Tax 3Jordi Casteleyn <br />Pfizer <br />
  2. 2. Summary<br />History<br />Turnover 2009 – 2010 – Q1<br />Turnover 2009 – 2010 – Q2<br />Turnover 2009 – 2010 – Q3<br />Turnover 2009 – 2010 – Q4<br />Ratio’s<br />Sources<br />
  3. 3. History<br />Pfizer is named after the German-American cousins Charles Pfizer and Charles Erhat (born in germany)<br />They launched a chemical business in Brooklyn, 1849.<br />Since 1950 Pfizer had expended its company to Belgium<br />
  4. 4. Turnover 2010 – 2009 - Q1<br />
  5. 5. Conclusion Q1<br />The Biopharmaceutical has increased with 44% since last year<br />The salesnumbers of the diversified products have increased since last year with 210%!<br />And the total turnover has increased with 53%<br />
  6. 6. Turnover 2010 – 2009 – Q2<br />
  7. 7. Conclusion Q2<br />When we compare the Bioparmaceutical of the 2nd quarter, we can see that it has an increase of 49%.<br />When we look at the Nutrition and Consumer Healthcare, the numbers aren’t applicable but we can notice that the numbers are troumendous!<br />The total increase of the salesnumber is 58% <br />
  8. 8. Turnover 2010 – 2009 – Q3<br />
  9. 9. Conclusion Q3<br />The total of this quarter has the least salesnumbers opposite the other 3 quarters.<br />When we compare the third quarter with last years third quarter, we can adopt that there is an increase of 39%.<br />
  10. 10. Turnover 2010 – 2009 – Q4<br />
  11. 11. Conclusion Q4<br />The turnover has climbed since last year<br />The recent 4th quarter is better then the 4th quarter of last year.<br />Generally it has the most salesnumbers of the year when we compare it with the other 3 quarters.<br />
  12. 12. Ratio Pfizer Belgium “Puurs”<br />
  13. 13. Sources<br />http://www.pfizer.be/sites/be/nl/about_pfizer/who_we_are/history/Pages/default.aspx <br />http://www.pfizer.com/files/news/press_releases/2010/pfizer_1q_2010_earnings_050410.pdf<br />http://www.pfizer.com/files/investors/presentations/q2performance_080310.pdf<br />http://media.pfizer.com/files/investors/presentations/q3performance_110210.pdf<br />http://www.pfizer.com/files/investors/presentations/q4performance_020111.pdf<br />

×